ProfileGDS4718 / 208266_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 33% 41% 36% 42% 33% 27% 35% 48% 38% 37% 37% 39% 31% 33% 33% 37% 36% 36% 31% 39% 46% 39% 42% 32% 40% 33% 36% 33% 31% 39% 30% 32% 47% 37% 30% 30% 30% 39% 42% 34% 41% 35% 30% 28% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.6935333
GSM549102patient 115, normal, homogenized [OPG study]5.0570841
GSM549104patient 119, normal, homogenized [OPG study]4.8030536
GSM549108patient 138, normal, homogenized [OPG study]5.1598742
GSM549119patient 077, normal, homogenized [OPG study]4.6773133
GSM549133patient 032, cancer, homogenized [OPG study]4.3576327
GSM549139patient 042, cancer, homogenized [OPG study]4.7280335
GSM549099patient 107, normal, homogenized [OPG study]5.4221648
GSM549109patient 139, normal, homogenized [OPG study]4.9052438
GSM549110patient 046, normal, homogenized [OPG study]4.8376337
GSM549114patient 063, normal, homogenized [OPG study]4.8106237
GSM549122patient 082, normal, homogenized [OPG study]4.9468539
GSM549134patient 033, cancer, homogenized [OPG study]4.5782831
GSM549136patient 036, cancer, homogenized [OPG study]4.5961533
GSM549140patient 044, cancer, homogenized [OPG study]4.6345533
GSM549111patient 047, normal, homogenized [OPG study]4.8382337
GSM549113patient 057, normal, homogenized [OPG study]4.7557636
GSM549132patient 031, cancer, homogenized [OPG study]4.7802736
GSM549137patient 038, cancer, homogenized [OPG study]4.5819631
GSM549142patient 047, cancer, homogenized [OPG study]5.0767239
GSM549100patient 110, normal, homogenized [OPG study]5.3167646
GSM549107patient 135, normal, homogenized [OPG study]4.9131539
GSM549115patient 068, normal, homogenized [OPG study]5.022942
GSM549116patient 072, normal, homogenized [OPG study]4.598732
GSM549120patient 078, normal, homogenized [OPG study]4.9995440
GSM549131patient 030, cancer, homogenized [OPG study]4.6039133
GSM549118patient 074, normal, homogenized [OPG study]4.7836836
GSM549129patient 027, cancer, homogenized [OPG study]4.6904433
GSM549123patient 088, normal, homogenized [OPG study]4.5816831
GSM549124patient 006, cancer, homogenized [OPG study]4.9577639
GSM549126patient 015, cancer, homogenized [OPG study]4.5469430
GSM549128patient 025, cancer, homogenized [OPG study]4.5914932
GSM549103patient 117, normal, homogenized [OPG study]5.3844147
GSM549117patient 073, normal, homogenized [OPG study]4.8358537
GSM549138patient 041, cancer, homogenized [OPG study]4.5180630
GSM549141patient 045, cancer, homogenized [OPG study]4.4577330
GSM549130patient 028, cancer, homogenized [OPG study]4.5617330
GSM549101patient 111, normal, homogenized [OPG study]5.0022339
GSM549105patient 128, normal, homogenized [OPG study]5.1086542
GSM549106patient 134, normal, homogenized [OPG study]4.6717934
GSM549112patient 048, normal, homogenized [OPG study]5.0332741
GSM549125patient 011, cancer, homogenized [OPG study]4.7656935
GSM549127patient 024, cancer, homogenized [OPG study]4.5298730
GSM549135patient 035, cancer, homogenized [OPG study]4.4067228